vs
Side-by-side financial comparison of Arhaus, Inc. (ARHS) and Bio-Techne (TECH). Click either name above to swap in a different company.
Arhaus, Inc. is the larger business by last-quarter revenue ($364.8M vs $295.9M, roughly 1.2× Bio-Techne). Bio-Techne runs the higher net margin — 12.8% vs 4.1%, a 8.7% gap on every dollar of revenue. On growth, Arhaus, Inc. posted the faster year-over-year revenue change (5.1% vs -6.4%). Over the past eight quarters, Arhaus, Inc.'s revenue compounded faster (11.2% CAGR vs 4.2%).
Arhaus, Inc.ARHSEarnings & Financial Report
Arhaus, Inc. is an upscale American home furnishings company headquartered in Boston Heights, Ohio. Founded in 1986 with a focus on sustainability and artisanship in product quality, Arhaus provides a diversified assortment of specialty goods and services addressing omnichannel direct-to-consumer and business-to-business residential and commercial operations.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
ARHS vs TECH — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $364.8M | $295.9M |
| Net Profit | $15.1M | $38.0M |
| Gross Margin | 38.1% | 64.6% |
| Operating Margin | 5.6% | 18.4% |
| Net Margin | 4.1% | 12.8% |
| Revenue YoY | 5.1% | -6.4% |
| Net Profit YoY | -29.1% | 68.3% |
| EPS (diluted) | $0.11 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $364.8M | $295.9M | ||
| Q3 25 | $344.6M | — | ||
| Q2 25 | $358.4M | $317.0M | ||
| Q1 25 | $311.4M | $316.2M | ||
| Q4 24 | $347.0M | $297.0M | ||
| Q3 24 | $319.1M | $289.5M | ||
| Q2 24 | $309.8M | $306.1M | ||
| Q1 24 | $295.2M | $303.4M |
| Q4 25 | $15.1M | $38.0M | ||
| Q3 25 | $12.2M | — | ||
| Q2 25 | $35.1M | $-17.7M | ||
| Q1 25 | $4.9M | $22.6M | ||
| Q4 24 | $21.3M | $34.9M | ||
| Q3 24 | $9.9M | $33.6M | ||
| Q2 24 | $22.2M | $40.6M | ||
| Q1 24 | $15.1M | $49.1M |
| Q4 25 | 38.1% | 64.6% | ||
| Q3 25 | 38.7% | — | ||
| Q2 25 | 41.4% | 62.7% | ||
| Q1 25 | 37.1% | 67.9% | ||
| Q4 24 | 40.0% | 65.3% | ||
| Q3 24 | 38.6% | 63.2% | ||
| Q2 24 | 40.1% | 66.4% | ||
| Q1 24 | 39.0% | 67.4% |
| Q4 25 | 5.6% | 18.4% | ||
| Q3 25 | 4.8% | — | ||
| Q2 25 | 13.0% | -7.5% | ||
| Q1 25 | 1.7% | 12.2% | ||
| Q4 24 | 8.2% | 16.0% | ||
| Q3 24 | 3.3% | 13.8% | ||
| Q2 24 | 9.5% | 15.0% | ||
| Q1 24 | 6.2% | 22.1% |
| Q4 25 | 4.1% | 12.8% | ||
| Q3 25 | 3.5% | — | ||
| Q2 25 | 9.8% | -5.6% | ||
| Q1 25 | 1.6% | 7.1% | ||
| Q4 24 | 6.1% | 11.7% | ||
| Q3 24 | 3.1% | 11.6% | ||
| Q2 24 | 7.2% | 13.3% | ||
| Q1 24 | 5.1% | 16.2% |
| Q4 25 | $0.11 | $0.24 | ||
| Q3 25 | $0.09 | — | ||
| Q2 25 | $0.25 | $-0.11 | ||
| Q1 25 | $0.03 | $0.14 | ||
| Q4 24 | $0.15 | $0.22 | ||
| Q3 24 | $0.07 | $0.21 | ||
| Q2 24 | $0.16 | $0.26 | ||
| Q1 24 | $0.11 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $253.4M | $172.9M |
| Total DebtLower is stronger | — | $260.0M |
| Stockholders' EquityBook value | $418.2M | $2.0B |
| Total Assets | $1.4B | $2.5B |
| Debt / EquityLower = less leverage | — | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $253.4M | $172.9M | ||
| Q3 25 | $262.2M | — | ||
| Q2 25 | $234.8M | $162.2M | ||
| Q1 25 | $214.4M | $140.7M | ||
| Q4 24 | $197.5M | $177.5M | ||
| Q3 24 | $177.7M | $187.5M | ||
| Q2 24 | $174.2M | $152.9M | ||
| Q1 24 | $233.2M | $145.3M |
| Q4 25 | — | $260.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $346.0M | ||
| Q1 25 | — | $330.0M | ||
| Q4 24 | — | $300.0M | ||
| Q3 24 | — | $300.0M | ||
| Q2 24 | — | $319.0M | ||
| Q1 24 | — | $389.0M |
| Q4 25 | $418.2M | $2.0B | ||
| Q3 25 | $400.4M | — | ||
| Q2 25 | $385.6M | $1.9B | ||
| Q1 25 | $348.8M | $2.0B | ||
| Q4 24 | $343.7M | $2.1B | ||
| Q3 24 | $320.6M | $2.1B | ||
| Q2 24 | $309.3M | $2.1B | ||
| Q1 24 | $285.6M | $2.0B |
| Q4 25 | $1.4B | $2.5B | ||
| Q3 25 | $1.4B | — | ||
| Q2 25 | $1.3B | $2.6B | ||
| Q1 25 | $1.3B | $2.6B | ||
| Q4 24 | $1.2B | $2.7B | ||
| Q3 24 | $1.2B | $2.7B | ||
| Q2 24 | $1.2B | $2.7B | ||
| Q1 24 | $1.2B | $2.7B |
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× | ||
| Q1 24 | — | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $9.3M | — |
| Free Cash FlowOCF − Capex | $-8.8M | — |
| FCF MarginFCF / Revenue | -2.4% | — |
| Capex IntensityCapex / Revenue | 5.0% | — |
| Cash ConversionOCF / Net Profit | 0.62× | — |
| TTM Free Cash FlowTrailing 4 quarters | $59.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $9.3M | — | ||
| Q3 25 | $46.1M | — | ||
| Q2 25 | $34.9M | $98.2M | ||
| Q1 25 | $46.5M | $41.1M | ||
| Q4 24 | $31.7M | $84.3M | ||
| Q3 24 | $31.1M | $63.9M | ||
| Q2 24 | $47.5M | $75.5M | ||
| Q1 24 | $36.8M | $81.0M |
| Q4 25 | $-8.8M | — | ||
| Q3 25 | $28.0M | — | ||
| Q2 25 | $20.9M | $93.3M | ||
| Q1 25 | $18.9M | $31.0M | ||
| Q4 24 | $13.0M | $77.5M | ||
| Q3 24 | $4.6M | $54.7M | ||
| Q2 24 | $11.3M | $57.5M | ||
| Q1 24 | $10.9M | $64.5M |
| Q4 25 | -2.4% | — | ||
| Q3 25 | 8.1% | — | ||
| Q2 25 | 5.8% | 29.4% | ||
| Q1 25 | 6.1% | 9.8% | ||
| Q4 24 | 3.7% | 26.1% | ||
| Q3 24 | 1.4% | 18.9% | ||
| Q2 24 | 3.6% | 18.8% | ||
| Q1 24 | 3.7% | 21.3% |
| Q4 25 | 5.0% | — | ||
| Q3 25 | 5.3% | — | ||
| Q2 25 | 3.9% | 1.5% | ||
| Q1 25 | 8.9% | 3.2% | ||
| Q4 24 | 5.4% | 2.3% | ||
| Q3 24 | 8.3% | 3.2% | ||
| Q2 24 | 11.7% | 5.9% | ||
| Q1 24 | 8.8% | 5.4% |
| Q4 25 | 0.62× | — | ||
| Q3 25 | 3.77× | — | ||
| Q2 25 | 1.00× | — | ||
| Q1 25 | 9.53× | 1.82× | ||
| Q4 24 | 1.49× | 2.42× | ||
| Q3 24 | 3.14× | 1.90× | ||
| Q2 24 | 2.14× | 1.86× | ||
| Q1 24 | 2.44× | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ARHS
| Sales Channel Retail | $305.7M | 84% |
| Sales Channel E Commerce | $59.2M | 16% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
